Blog Posts

Jennifer Plichta: Tori Chanenchuk on Breast Cancer Staging at ASBrS2025

Jennifer Plichta/X

May 11, 2025, 18:05

Jennifer Plichta: Tori Chanenchuk on Breast Cancer Staging at ASBrS2025

Jennifer Plichta, Director of Breast Risk Assessment Clinic at Duke University Health System, shared a post on X:

“Phenomenal meeting ASBrS2025. Proud of Tori Chanenchuk presenting our work on breast cancer staging. Always fun spending time with Duke Breast. Wonderful to see so many friends.”

Jennifer Plichta

ASBrS2025 cancer Duke University School of Medicine Jennifer Plichta OncoDaily Oncology Tori Chanenchuk

Neil Ranasinghe: What’s the Difference Between a Clinician and a Technical Author?

LOCKTAC Molecular Glues Are Changing the Rules of Drug Discovery - Amgen

Top 10 Immunotherapy Trials in Lung Cancer to Watch at ESMO 2025

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Voices

Aug 25, 2025, 18:30

Shadha S. Al-Raisi: The Latest Cancer Incidence Report in Oman Has Been Released

Insight

Aug 25, 2025, 17:47

Alexey Kulikov: Key Findings from the Recent Meta-Analysis on Daily Steps and Health Outcomes

Voices

Aug 25, 2025, 17:36

Lauren Kriger Groner: Learning to Make White Ribbons from the Very Best

Science

Aug 25, 2025, 17:28

Galip Can Uyar: How GA-Guided Care Improves Coping in Older Adults with Metastatic Cancer

Science

Aug 25, 2025, 17:18

Giuseppe Banna: Deferred Nephrectomy after ICI in RCC May Enable Treatment De-Escalation

Science

Aug 25, 2025, 17:08

Moazzam Shahzad: Upfront Immunotherapy Approaches in the Management of Adults with ALL

Science

Aug 25, 2025, 17:00

Chris Poulios: Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma

Voices

Aug 25, 2025, 16:44

Martin Zapata Laguado: Honored to Speak on mRCC First-Line Therapy and dCN in the IO Era

Voices

Aug 25, 2025, 16:30

Sarcoma 101 at Fellowship Bootcamp with Steve Bialick - Miami Hematology Oncology Program Director

Science

Aug 25, 2025, 16:04

George Kumar Shares Breakthrough in Cold Plasma Oncology

Voices

Aug 25, 2025, 15:59

Cancer Research Institute Highlights Its Role in Immune-Based Cancer Breakthroughs

Voices

Aug 25, 2025, 15:59

Al-Ola Abdallah Shares Inspiring Patient Recoveries in Myeloma Clinic